BioSyent Inc.

TSXV:RX Stock Report

Market Cap: CA$133.5m

BioSyent Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:RX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24SellCA$5,039Seyed AshrafiIndividual419CA$12.04
04 Dec 24SellCA$305,291FAX Capital Corp.Company27,500CA$11.10
25 Nov 24SellCA$7,294Peter LockhardIndividual637CA$11.45
22 Nov 24SellCA$2,619,768FAX Capital Corp.Company235,500CA$11.33
22 Nov 24SellCA$3,143,901FAX Capital Corp.Company300,500CA$11.33
30 Sep 24SellCA$23,455Sharan RaghubirIndividual2,213CA$10.81
23 Sep 24SellCA$7,050Peter LockhardIndividual635CA$11.15
23 Jul 24SellCA$5,025,000FAX Capital Corp.Company500,000CA$10.05
28 Jun 24SellCA$4,247Sharan RaghubirIndividual423CA$10.04
20 Jun 24SellCA$55,112Sharan RaghubirIndividual5,505CA$10.01
12 Jun 24SellCA$14,276René GoehrumIndividual1,522CA$9.38
22 May 24BuyCA$92,870Canadian Western Trust, Asset Management ArmCompany10,800CA$8.65
22 May 24SellCA$5,666Peter LockhardIndividual632CA$9.00
29 Apr 24BuyCA$171,294Canadian Western Trust, Asset Management ArmCompany20,000CA$8.60
28 Mar 24BuyCA$17,400Larry AndrewsIndividual2,000CA$8.70
28 Mar 24SellCA$4,837Peter LockhardIndividual556CA$8.70
26 Mar 24SellCA$5,220Peter LockhardIndividual600CA$8.70

Insider Trading Volume

Insider Buying: RX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of RX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,087,7619.57%
Individual Insiders1,515,71813.3%
Institutions2,188,55119.2%
General Public6,577,62657.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 42.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.6%
FAX Capital Corp.
1,318,100CA$15.5m-19.9%100.0%
9.57%
1069867 Ontario Ltd
1,087,761CA$12.8m0%no data
8.78%
René Goehrum
997,970CA$11.7m0%no data
4.4%
Intrepid Equity Finance Ltd., Investment Arm
500,000CA$5.9m0%no data
1.79%
Canadian Western Trust, Asset Management Arm
203,294CA$2.4m-1.06%100.0%
1.57%
Peter Lockhard
179,019CA$2.1m-0.35%no data
1.42%
Grandeur Peak Global Advisors, LLC
161,287CA$1.9m0%0.03%
0.57%
Kevin Wilson
64,782CA$760.5k0%no data
0.49%
Robert March
56,254CA$660.4k0%no data
0.46%
Joost van der Mark
52,730CA$619.1k0%no data
0.4%
Seyed Ashrafi
45,110CA$529.6k-0.92%no data
0.3%
Sharan Raghubir
33,853CA$397.4k-6.14%no data
0.18%
Neelu Atwal
20,175CA$236.9k0%no data
0.15%
Ramesh Moothan
17,502CA$205.5k0%no data
0.13%
Sara Elford
15,151CA$177.9k0%no data
0.099%
Joseph Arcuri
11,273CA$132.3k9.29%no data
0.085%
Larry Andrews
9,684CA$113.7k0%no data
0.08%
Marnie Mccormick
9,060CA$106.4k0%no data
0.052%
Van Berkom and Associates Inc.
5,870CA$68.9k0%no data
0.028%
Stephen Wilton
3,155CA$37.0k21.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioSyent Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Scott CurtisCantor Fitzgerald Canada Corporation
Tania Armstrong-WhitworthCormark Securities Inc.